Janus Henderson Group plc 13D and 13G filings for Benitec Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-12-06 1:47 pm Purchase | 2024-11-29 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 2,692,410 11.600% | 1,815,887 (+207.17%) | Filing |
2024-11-14 1:37 pm Sale | 2024-09-30 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 876,523 8.300% | -1,805,752 (-67.32%) | Filing |
2024-11-06 3:26 pm Unchanged | 2024-10-31 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 2,682,275 13.500% | 0 (Unchanged) | Filing |
2024-10-25 2:19 pm Purchase | 2024-10-21 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 2,682,275 13.500% | 2,501,876 (+1386.86%) | Filing |
2024-02-14 10:00 am Sale | 2023-12-31 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 180,399 7.000% | -25,771 (-12.50%) | Filing |
2023-08-18 3:55 pm Purchase | 2023-08-09 | 13G | Benitec Biopharma Inc. BNTC | JANUS HENDERSON GROUP PLC JHG | 206,170 9.900% | 206,170 (New Position) | Filing |